New hope for rheumatoid arthritis sufferers: ELV001 trial launches
Disease control
Recruiting now
This study tests an experimental drug called ELV001 in people with active rheumatoid arthritis who haven't gotten enough relief from standard treatments like methotrexate or TNF inhibitors. About 180 adults aged 18 to 75 will receive either ELV001 or a placebo alongside their cur…
Phase: PHASE2 • Sponsor: Elevara Medicines Limited • Aim: Disease control
Last updated May 05, 2026 11:55 UTC